Research

  SP on Dementia and Cognitive Disorders Panel met during recent EAN Congress in Amsterdam. Co-chairs Reinhold Schmidt from Austria and Jakub Hort from Czech Republic welcomed members and announced that Prof. Dafin Muresanu from Romania has been appointed as… Continue Reading

  The Panel met at the EAN Congress in Amsterdam and the Co-Chairs presented the main points from the Panel Chairs meeting.  It was agreed that the Panel would approach all members to suggest a Neurologist in training to join… Continue Reading

A new guideline on cerebral venous thrombosis (CVT) diagnosis and treatment issued by the European Stroke Organization (ESO) and endorsed by the European Academy of Neurology (EAN) was recently published in ESO (long version) and EAN (abbreviated version) official journals [1, 2].

It is a pleasure to share with the European neurological community the outcome of the first teaching course for rare neurological diseases. The course took place in Cluj-Napoca, Romania, from 7th to 9th September 2017.

For October 2017, we have selected: Andersen G, Hedermann G, Witting N, Duno M, Andersen H, Vissing J. The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study. Brain 2017;140:2295-2305. Patients with myotonia congenita and paramyotonia congenita can be disabled by the myotonic phenomenon in the activities of daily living, with a huge impact on their quality of life.

  SP Pain met during recent EAN Congress in Amsterdam. Co-chair Nadine Attal from France welcomed members and presented last year panel’s activities. Last year was successful. SP Pain co-chairs Nadine Attal and Giorgio Cruccu had, together with members of… Continue Reading

  SP Neurotraumatology met during recent EAN Congress in Amsterdam. Co-chairs Pieter Vos from the Netherlands and Oliver Kastrup from Germany welcomed members and introduced Dafin Muresanu from Romania, as a new liaison officer between the scientific committee and scientific… Continue Reading

For September 2017, we have selected: Hoffman EM, Watson JC, St Sauver J, Staff NP, Klein CJ. Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy. JAMA Neurology 2017;74:773-779. Neuropathic pain is a common symptom in polyneuropathy that can be difficult to manage. Opioids are usually recommended as second-line treatment, with primary care physicians being mainly involved in opioid prescription.

Antonio Federico: What are the aims of your ERN? Helen Cross: The objectives of the EpiCARE network will be: To improve accessibility of detailed diagnostics to individuals of all ages with rare and complex epilepsies across Europe, including clinical evaluation and investigation.

A session on neurological palliative care was included within the 15th World Congress of the European Association for Palliative Care in Madrid on 18th May.  In 2016, a Memorandum of Understanding was signed between the EAPC and the EAN and… Continue Reading

ntonio Federico: What are the aims of your ERN? Teresinha Evangelista: Our MISSION: Through collaborative cross-border work the EURO-NMD ERN will improve the lives of EU citizens by improving diagnosis, treatment and the delivery of high-quality, accessible and cost-effective healthcare to patients with rare Neuromuscular Diseases (NMD) requiring a particular concentration of resources or expertise.

The EAN Rare neurological diseases task force will be holding its 1st teaching course under the auspices of Dafin F. Muresanu, Professor of Neurology at the “Iuliu Hatieganu” University of Medicine and Pharmacy, in Cluj-Napoca, Romania. This teaching course aims… Continue Reading